Latest Period
Q4 2025
Security Snapshot
Legend Biotech Corp - Ordinary Shares (LEGN) Institutional Ownership
CUSIP: 52490G102
13F Institutional Holders and Ownership History from Q2 2020 to Q1 2026
Institutions Reporting
195
Shares (Excl. Options)
87,561,169
Price
$21.74
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Ordinary Shares
- Symbol
- LEGN on Nasdaq
- Shares outstanding
- 368,659,889
- Price per share
- $18.09
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 87,561,169
- Total reported value
- $1,903,177,624
- % of total 13F portfolios
- 0%
- Share change
- +2,754,659
- Value change
- +$14,993,044
- Number of holders
- 195
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- LEGN - Legend Biotech Corp - Ordinary Shares is tracked under CUSIP 52490G102.
- 195 institutions reported positions in Q4 2025.
- 2 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 195 to 70 between Q4 2025 and Q1 2026.
- Reported value moved from $1,903,177,624 to $114,655,470.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 195 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 52490G102?
CUSIP 52490G102 identifies LEGN - Legend Biotech Corp - Ordinary Shares in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 52490G102:
Significant Owners of Legend Biotech Corp - Ordinary Shares (LEGN) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 13% | -13% | $1,049,921,245 | -$147,815,434 | 48,294,445 | -12% | FMR LLC | 31 Dec 2025 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.7% | $233,379,028 | 6,808,023 | T. Rowe Price Associates, Inc. | 31 Dec 2024 |
As of 31 Dec 2025, 195 institutional investors reported holding 87,561,169 shares of Legend Biotech Corp - Ordinary Shares (LEGN). This represents 24% of the company’s total 368,659,889 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Legend Biotech Corp - Ordinary Shares (LEGN) together control 20% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 6.6% | 24,268,223 | -12% | 0.03% | $527,591,163 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1.8% | 6,608,629 | +73% | 3.6% | $143,671,594 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1.7% | 6,164,677 | +1.2% | 0.56% | $134,020,083 |
| HHLR ADVISORS, LTD. | 1.6% | 5,984,550 | 0% | 4.2% | $130,104,117 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 1.6% | 5,932,000 | +100% | 1.7% | $128,961,680 |
| BlackRock, Inc. | 1.2% | 4,276,913 | -4.8% | 0% | $92,980,090 |
| Point72 Asset Management, L.P. | 0.76% | 2,784,806 | 0.09% | $60,541,682 | |
| Artisan Partners Limited Partnership | 0.64% | 2,341,074 | -8.1% | 0.08% | $50,894,949 |
| GOLDMAN SACHS GROUP INC | 0.59% | 2,174,535 | +106% | 0.01% | $47,274,391 |
| ALLIANCEBERNSTEIN L.P. | 0.41% | 1,517,067 | -7.1% | 0.01% | $32,981,037 |
| STATE STREET CORP | 0.41% | 1,516,368 | +31% | 0% | $32,965,840 |
| BRAIDWELL LP | 0.35% | 1,298,142 | -29% | 0.9% | $28,221,607 |
| Davern Capital Partners, LP | 0.29% | 1,056,668 | 0% | 7.4% | $22,971,962 |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 0.26% | 956,824 | -7% | 6.3% | $20,801,354 |
| JPMORGAN CHASE & CO | 0.26% | 945,694 | +205% | 0% | $20,559,386 |
| Capital International Investors | 0.26% | 941,600 | 0% | 0% | $20,470,384 |
| JOHNSON & JOHNSON | 0.22% | 814,586 | 0% | 3.2% | $17,709,100 |
| IvyRock Asset Management (HK) Ltd | 0.22% | 804,000 | -6.2% | 9.2% | $17,478,960 |
| MARSHALL WACE, LLP | 0.21% | 755,953 | +4130% | 0.02% | $16,434,418 |
| ArrowMark Colorado Holdings LLC | 0.2% | 721,790 | -23% | 0.35% | $15,691,715 |
| TWO SIGMA ADVISERS, LP | 0.19% | 689,600 | -4.7% | 0.03% | $14,991,904 |
| ACADIAN ASSET MANAGEMENT LLC | 0.16% | 582,154 | 0.02% | $12,647,000 | |
| Hudson Bay Capital Management LP | 0.16% | 575,000 | +161% | 0.07% | $12,500,500 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.15% | 555,436 | +2.9% | 0% | $11,980,293 |
| TWO SIGMA INVESTMENTS, LP | 0.14% | 526,070 | +46% | 0.02% | $11,436,762 |
Institutional Holders of Legend Biotech Corp - Ordinary Shares (LEGN) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 6,352,479 | $114,655,470 | +$12,006,172 | $18.09 | 70 |
| 2025 Q4 | 87,561,169 | $1,903,177,624 | +$14,993,044 | $21.74 | 195 |
| 2025 Q3 | 83,685,243 | $2,727,887,108 | -$49,026,070 | $32.61 | 198 |
| 2025 Q2 | 84,637,633 | $3,002,800,929 | -$25,701,898 | $35.49 | 209 |
| 2025 Q1 | 85,585,612 | $2,906,390,112 | -$451,293,431 | $33.93 | 205 |
| 2024 Q4 | 99,259,008 | $3,230,144,565 | +$188,311,867 | $32.54 | 205 |
| 2024 Q3 | 91,083,902 | $4,438,353,408 | +$43,810,918 | $48.73 | 204 |
| 2024 Q2 | 91,534,759 | $4,053,943,715 | +$152,693,975 | $44.29 | 173 |
| 2024 Q1 | 86,480,093 | $4,850,469,897 | +$24,114,634 | $56.09 | 187 |
| 2023 Q4 | 85,815,138 | $5,163,245,741 | -$85,151,940 | $60.17 | 204 |
| 2023 Q3 | 85,989,090 | $5,775,420,098 | +$112,052,258 | $67.17 | 198 |
| 2023 Q2 | 84,064,242 | $5,802,906,378 | +$1,140,343,215 | $69.03 | 191 |
| 2023 Q1 | 68,026,089 | $3,279,762,243 | +$214,876,512 | $48.22 | 158 |
| 2022 Q4 | 63,494,614 | $3,169,508,515 | -$28,958,118 | $49.92 | 167 |
| 2022 Q3 | 63,810,382 | $2,603,349,501 | +$399,712,134 | $40.80 | 154 |
| 2022 Q2 | 52,707,652 | $2,898,825,468 | +$118,361,366 | $55.00 | 147 |
| 2022 Q1 | 51,010,221 | $1,853,796,102 | +$18,669,383 | $36.34 | 137 |
| 2021 Q4 | 50,201,932 | $2,340,358,513 | +$500,109,001 | $46.61 | 137 |
| 2021 Q3 | 39,005,848 | $1,971,657,000 | +$572,564,727 | $50.56 | 87 |
| 2021 Q2 | 28,328,593 | $1,162,838,000 | +$121,639,656 | $41.05 | 84 |
| 2021 Q1 | 26,391,052 | $765,864,420 | +$30,109,528 | $29.02 | 69 |
| 2020 Q4 | 25,444,505 | $716,732,000 | +$16,894,703 | $28.16 | 60 |
| 2020 Q3 | 24,479,702 | $752,680,000 | -$30,044,903 | $30.87 | 50 |
| 2020 Q2 | 24,613,241 | $1,036,097,000 | +$1,036,097,000 | $42.56 | 76 |